GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

I Sens 099190.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

12,210

-0.81%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩315.44bn

FY2016FY2025

Net income

−₩5.15bn

FY2016FY2025

Free cash flow

−₩8.34bn

FY2016FY2025

Shareholders' equity

₩315.25bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩315.44bn₩291.14bn₩265.12bn₩264.84bn₩232.93bn₩203.71bn₩189.84bn₩173.00bn₩156.96bn₩132.47bn
Gross profit₩125.26bn₩129.45bn₩106.06bn₩105.49bn₩102.06bn₩95.79bn₩97.46bn₩77.72bn₩69.20bn₩61.83bn
Research and development₩32.65bn₩30.26bn₩27.00bn₩26.97bn₩21.89bn₩18.91bn₩16.48bn₩13.35bn₩13.61bn₩11.83bn
Operating income₩7.89bn₩6.52bn₩7.18bn₩19.99bn₩34.90bn₩39.00bn₩30.80bn₩27.40bn₩23.35bn₩24.87bn
Net income−₩5.15bn−₩1.79bn₩3.71bn₩16.14bn₩25.45bn₩26.84bn₩23.43bn₩22.62bn₩15.73bn₩17.56bn
Diluted earnings per share-186.65-64.91134.83587.63936.041,974.141,723.121,641.131,141.981,279.96

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩577.66bn₩590.87bn₩498.82bn₩449.57bn₩429.18bn₩307.03bn₩270.04bn₩252.05bn₩234.08bn₩215.07bn
Cash and short-term investments—₩119.14bn₩51.87bn₩72.52bn₩100.67bn₩81.45bn₩46.39bn₩28.02bn₩28.01bn₩27.71bn
Total liabilities₩239.34bn₩247.89bn₩195.32bn₩163.76bn₩160.85bn₩87.54bn₩71.48bn₩71.12bn₩71.28bn₩65.39bn
Debt₩61.52bn₩173.77bn₩143.79bn₩100.85bn₩100.87bn₩50.17bn₩36.53bn₩38.63bn₩42.03bn₩35.22bn
Shareholders' equity₩315.25bn₩324.70bn₩284.35bn₩285.81bn₩268.33bn₩219.49bn₩198.56bn₩180.93bn₩162.80bn₩149.67bn
Shares outstanding28m28m28m27m27m14m14m14m14m14m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₩20.12bn₩22.96bn₩13.05bn₩6.65bn₩17.22bn₩34.61bn₩37.95bn₩19.54bn₩22.38bn₩11.73bn
Capital spending−₩28.46bn−₩15.58bn−₩42.65bn−₩23.27bn−₩47.63bn−₩7.64bn−₩6.93bn−₩8.82bn−₩23.66bn−₩8.59bn
Free cash flow−₩8.34bn₩7.38bn−₩29.60bn−₩16.61bn−₩30.41bn₩26.98bn₩31.03bn₩10.73bn−₩1.28bn₩3.13bn
Dividends paid−₩2.76bn−₩2.75bn−₩4.81bn−₩4.08bn−₩3.40bn−₩2.72bn−₩2.04bn−₩1.37bn−₩1.37bn−₩1.37bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩88.67bn₩75.13bn₩83.66bn₩78.73bn₩76.79bn₩76.27bn₩81.31bn₩71.52bn
Gross profit₩38.38bn₩31.85bn₩34.06bn₩28.94bn₩31.48bn₩30.78bn₩27.94bn₩29.86bn
Operating income₩6.61bn₩937.3m₩2.05bn₩916.0m₩1.68bn₩3.24bn₩2.00bn₩3.82bn
Net income₩3.93bn₩1.96bn−₩8.22bn−₩396.4m₩867.1m₩2.60bn−₩2.38bn₩850.3m
Diluted earnings per share137.1868.29-287.02-14.3731.4394.58-86.1330.77
Cash from operations₩7.96bn−₩1.56bn₩13.30bn₩6.18bn−₩1.96bn₩2.60bn₩2.22bn₩7.26bn
Capital spending−₩11.78bn−₩7.78bn−₩8.43bn−₩6.02bn−₩7.86bn−₩6.16bn−₩3.94bn−₩5.95bn
Free cash flow−₩3.82bn−₩9.34bn₩4.88bn₩162.0m−₩9.82bn−₩3.56bn−₩1.71bn₩1.32bn
Total assets₩599.15bn₩591.04bn₩577.66bn₩583.47bn₩569.02bn₩583.01bn₩590.87bn₩550.19bn
Cash and short-term investments——————₩119.14bn₩106.79bn
Debt₩77.65bn₩70.24bn₩61.52bn₩72.32bn₩72.14bn₩112.05bn₩170.85bn₩123.62bn
Shareholders' equity₩339.99bn₩332.98bn₩315.25bn₩321.37bn₩320.39bn₩322.74bn₩324.70bn₩294.52bn

Financial ratios

Data as of 31 Aug 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2018FY2017
Gross margin39.7%44.5%40.0%39.8%43.8%47.0%——
Operating margin2.5%2.2%2.7%7.5%15.0%19.1%——
Net margin-1.6%-0.6%1.4%6.1%10.9%13.2%——
Return on equity-1.6%-0.6%1.3%5.6%9.5%12.2%——
Return on assets-0.9%-0.3%0.7%3.6%5.9%8.7%——
Free cash flow yield——————11.4%18.5%
Revenue growth8.3%9.8%0.1%13.7%14.3%7.3%——
Earnings growth187.0%-148.4%-77.0%-36.6%-5.2%14.6%——
Current ratio1.55x2.46x1.56x2.91x5.41x5.06x——
Debt to equity0.20x0.52x0.31x0.22x0.35x0.20x——
Equity ratio54.6%55.0%57.0%63.6%62.5%71.5%——
Interest coverage1.10x0.95x2.41x10.69x40.76x37.67x——
R&D as a share of sales10.3%10.4%10.2%10.2%9.4%9.3%——
Buybacks as a share of market value——————-0.1%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue6.0%9.1%12.0%
Operating income-26.7%-27.4%-9.5%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin42.0%41.0%42.2%43.6%
Operating margin2.4%3.7%7.3%10.5%
Net margin-1.1%1.1%4.1%6.8%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-85.2-235.2212.128.016.27.67.56.911.111.5
Price to sales1.41.43.01.71.81.00.90.91.11.5

Dividends and splits

Per share, in the currency the company pays

Paid for 10 years. Last went ex-dividend on 29 Dec 2025.

FY2025FY2024FY2022FY2021FY2020FY2019FY2018FY2017
Paid in the year200.00100.00175.00150.00125.00100.0075.0050.00
  • 2-for-1 split · 14 Mar 2023

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.